COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 169 filers reported holding COHERUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,210,638 | -60.5% | 2,730,117 | -54.9% | 0.00% | -60.0% |
Q2 2023 | $25,873,297 | +146.3% | 6,059,320 | +294.5% | 0.01% | +150.0% |
Q1 2023 | $10,505,576 | -4.3% | 1,535,903 | +10.8% | 0.00% | 0.0% |
Q4 2022 | $10,982,213 | +502.8% | 1,386,643 | +631.5% | 0.00% | – |
Q3 2022 | $1,822,000 | +12.1% | 189,562 | +50.5% | 0.00% | – |
Q1 2022 | $1,626,000 | +9.3% | 125,938 | +35.1% | 0.00% | – |
Q4 2021 | $1,488,000 | -59.0% | 93,241 | -58.7% | 0.00% | -100.0% |
Q3 2021 | $3,628,000 | +340.8% | 225,724 | +279.5% | 0.00% | – |
Q2 2021 | $823,000 | -88.2% | 59,478 | -87.5% | 0.00% | -100.0% |
Q1 2021 | $6,967,000 | +70.6% | 476,799 | +102.8% | 0.00% | +100.0% |
Q4 2020 | $4,085,000 | -19.8% | 235,090 | -15.4% | 0.00% | 0.0% |
Q3 2020 | $5,094,000 | +63.3% | 277,766 | +59.0% | 0.00% | 0.0% |
Q2 2020 | $3,119,000 | -42.4% | 174,658 | -47.7% | 0.00% | -50.0% |
Q1 2020 | $5,419,000 | +5.9% | 334,128 | +17.5% | 0.00% | 0.0% |
Q4 2019 | $5,119,000 | -63.9% | 284,256 | -59.3% | 0.00% | -66.7% |
Q3 2019 | $14,165,000 | +21.8% | 699,118 | +32.9% | 0.01% | +20.0% |
Q2 2019 | $11,627,000 | -66.3% | 526,131 | -79.2% | 0.01% | -70.6% |
Q1 2019 | $34,545,000 | +71.2% | 2,532,682 | +13.6% | 0.02% | +54.5% |
Q4 2018 | $20,183,000 | -37.3% | 2,230,210 | +14.2% | 0.01% | -21.4% |
Q3 2018 | $32,212,000 | +8.0% | 1,952,201 | -8.4% | 0.01% | -6.7% |
Q2 2018 | $29,828,000 | +58.2% | 2,130,551 | +24.9% | 0.02% | +50.0% |
Q1 2018 | $18,852,000 | +20.9% | 1,706,022 | -3.7% | 0.01% | +11.1% |
Q4 2017 | $15,595,000 | +506.3% | 1,772,241 | +819.9% | 0.01% | +350.0% |
Q3 2017 | $2,572,000 | -26.7% | 192,659 | -21.2% | 0.00% | -33.3% |
Q2 2017 | $3,509,000 | +7.4% | 244,566 | +58.3% | 0.00% | 0.0% |
Q1 2017 | $3,267,000 | -44.6% | 154,467 | -26.3% | 0.00% | -50.0% |
Q4 2016 | $5,900,000 | +84.8% | 209,612 | +75.8% | 0.01% | +100.0% |
Q3 2016 | $3,192,000 | -72.0% | 119,231 | -82.4% | 0.00% | -76.9% |
Q2 2016 | $11,413,000 | +5283.5% | 675,732 | +9128.8% | 0.01% | – |
Q2 2015 | $212,000 | -52.3% | 7,322 | -49.5% | 0.00% | – |
Q1 2015 | $444,000 | – | 14,510 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |